Showing results (1-10 of 34) with videos related to
Sort By:
Pageof 4
Cancer Journal (Sudbury, Mass.)|March 22, 2021
Chimeric Antigen Receptor T Cells for B-Cell LymphomaRichard Newcomb, Caron JacobsonFrontiers in Oncology|June 21, 2024
The treatment of follicular lymphoma with CD19-directed chimeric antigen receptor T-cell therapyRyan Jacobs, Caron JacobsonCancer Journal (Sudbury, Mass.)|June 5, 2020
Immune and Cell Therapy in Non-Hodgkin LymphomaReid W Merryman, Roch Houot, Philippe Armand, et al.Health & Justice|December 23, 2014
Does gender matter? Exploring mental health recovery court legal and health outcomesCatherine L Kothari, Robert Butkiewicz, Emily R Williams, et al.Breast (Edinburgh, Scotland)|August 25, 2004
Cardiac toxicity observed in association with high-dose cyclophosphamide-based chemotherapy for metastatic breast cancerAmy Tiersten, Jennifer Wo, Caron Jacobson, et al.Neurology. Clinical Practice|September 26, 2022
Use of Transcranial Doppler as a Biomarker of CAR T Cell-Related NeurotoxicityKathryn B Holroyd, Daniel B Rubin, Sarah LaRose, et al.Neuro-Oncology|July 15, 2021
EEG findings in CAR T-cell-associated neurotoxicity: Clinical and radiological correlationsIsabelle Beuchat, Husain H Danish, Daniel B Rubin, et al.JAMA Neurology|August 11, 2020
Clinical Predictors of Neurotoxicity After Chimeric Antigen Receptor T-Cell TherapyDaniel B Rubin, Ali Al Jarrah, Karen Li, et al.British Journal of Haematology|October 20, 2025
Cardiovascular complications and their association with short- and long-term outcomes in patients with multiple myeloma undergoing chimeric antigen receptor T-cell therapyOsnat Itzhaki Ben Zadok, Panagiotis Simitsis, Caron Jacobson, et al.Pageof 4